Induction of Multidrug Resistance of Acute Myeloid Leukemia Cells by Cocultured Stromal Cells via Upregulation of the PI3K/Akt Signaling Pathway
暂无分享,去创建一个
Q. Yuan | Ping Chen | Huifang Huang | Xi Jiang | Q. Fu | Pei-Dong You | Q. Jin
[1] Luís Lima,et al. Abnormal Protein Glycosylation and Activated PI3K/Akt/mTOR Pathway: Role in Bladder Cancer Prognosis and Targeted Therapeutics , 2015, PloS one.
[2] H. Pan,et al. The expression of the PI3K/AKT/mTOR pathway in gastric cancer and its role in gastric cancer prognosis , 2015, OncoTargets and therapy.
[3] M. Konopleva,et al. Role of Microenvironment in Resistance to Therapy in AML , 2015, Current Hematologic Malignancy Reports.
[4] P. Panayiotidis,et al. Expression of three different ATP‐binding cassette transporters and correlation to chemoresistance in acute myeloid leukemia , 2015, International journal of laboratory hematology.
[5] M. Hirata,et al. Reduced ABCG2 and increased SLC22A1 mRNA expression are associated with imatinib response in chronic myeloid leukemia , 2014, Medical Oncology.
[6] Peter G. Smith,et al. Drug Efflux Transporters and Multidrug Resistance in Acute Leukemia: Therapeutic Impact and Novel Approaches to Mediation , 2012, Molecular Pharmacology.
[7] J. Dipersio,et al. Bone Marrow Stromal Cells Modulate Mouse ENT1 Activity and Protect Leukemia Cells from Cytarabine Induced Apoptosis , 2012, PloS one.
[8] K. Döhner,et al. Stromal niche cells protect early leukemic FLT3-ITD+ progenitor cells against first-generation FLT3 tyrosine kinase inhibitors. , 2011, Cancer research.
[9] S. Asano,et al. Adhesion-Induced Drug Resistance in Leukemia Stem Cells , 2010, Pharmacology.
[10] C. Peng,et al. Role of Pten in leukemia stem cells , 2010, Oncotarget.
[11] T. Çolakoğlu,et al. Clinicopathological significance of PTEN loss and the phosphoinositide 3-kinase/Akt pathway in sporadic colorectal neoplasms: is PTEN loss predictor of local recurrence? , 2008, American journal of surgery.
[12] M. Varella‐Garcia,et al. Multi-genetic events collaboratively contribute to Pten-null leukaemia stem-cell formation , 2008, Nature.
[13] Satoshi Tanaka,et al. Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region , 2007, Nature Biotechnology.
[14] E. Lam,et al. Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth , 2007, Leukemia.
[15] S. Morrison,et al. Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells , 2006, Nature.
[16] K. Al-Kuraya,et al. JAK Family of Tyrosine Kinases: Its Functions and Alterations in Human Cancer , 2006 .
[17] M. Oshimura,et al. PI3K-Akt pathway: Its functions and alterations in human cancer , 2004, Apoptosis.
[18] W. Gerald,et al. Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control , 2004, Nature.
[19] T. Ishida,et al. Constitutive activation of PI3K is involved in the spontaneous proliferation of primary acute myeloid leukemia cells: direct evidence of PI3K activation , 2004, Leukemia.
[20] J. Thiery,et al. Loss of heterozygosity on 10q and mutational status of PTEN and BMPR1A in colorectal primary tumours and metastases , 2004, British Journal of Cancer.
[21] M. Carroll,et al. Survival of acute myeloid leukemia cells requires PI3 kinase activation. , 2003, Blood.
[22] P. Dennis,et al. Activation of the PI3K/Akt pathway and chemotherapeutic resistance. , 2002, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[23] Kenneth M. Yamada,et al. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. , 1998, Science.